Literature DB >> 30075105

Motor Neuron Disease: Pathophysiology, Diagnosis, and Management.

Laura A Foster1, Mohammad Kian Salajegheh2.   

Abstract

Patients with motor neuron diseases may present to primary care clinic or may be initially encountered in the inpatient setting. Timely diagnosis of these conditions is a key factor in early intervention and therapy, and accuracy of diagnosis is of extreme importance, in particular for amyotrophic lateral sclerosis with its poor prognosis. The aim of this review article is to provide a clinical and diagnostic framework for the diagnosis and evaluation of motor neuron disease for primary care physicians.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Kennedy disease; Motor neuron disease; Poliomyelitis

Mesh:

Year:  2018        PMID: 30075105     DOI: 10.1016/j.amjmed.2018.07.012

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  A motor neuron protective role of miR-969 mediated by the transcription factor kay.

Authors:  Xiao Zhang; Jialan Lyu; Xiaoye Jin; Weiwei Yang; Ziwei Lou; Yongmei Xi; Xiaohang Yang; Wanzhong Ge
Journal:  RNA Biol       Date:  2020-05-13       Impact factor: 4.652

2.  A Case Report on Robot-Aided Gait Training in Primary Lateral Sclerosis Rehabilitation: Rationale, Feasibility and Potential Effectiveness of a Novel Rehabilitation Approach.

Authors:  Simona Portaro; Laura Ciatto; Loredana Raciti; Enrico Aliberti; Riccardo Aliberti; Antonino Naro; Rocco Salvatore Calabrò
Journal:  Innov Clin Neurosci       Date:  2021 Apr-Jun

3.  Identifying key signs of motor neurone disease in primary care: a nested case-control study using the QResearch database.

Authors:  Xue W Mei; Judith Burchardt; Tom A Ranger; Christopher J McDermott; Aleksandar Radunovic; Carol Coupland; Julia Hippisley-Cox
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

Review 4.  Perampanel for amyotrophic lateral sclerosis: A systematic review and meta-analysis.

Authors:  Christian Wilson R Turalde; Kevin Michael C Moalong; Adrian I Espiritu; Mario B Prado
Journal:  Neurol Sci       Date:  2022-01-07       Impact factor: 3.830

5.  Awaji criteria for the diagnosis of amyotrophic lateral sclerosis in Hanoi, Vietnam.

Authors:  Tuan Van Nguyen; Tuan Anh Tran; Hinh Thi Vu
Journal:  Neurol Sci       Date:  2021-05-22       Impact factor: 3.307

6.  Sustained safe and effective anticoagulation using Edoxaban via percutaneous endoscopic gastrostomy.

Authors:  Mattia Galli; Domenico D'Amario; Felicita Andreotti; Italo Porto; Rocco Vergallo; Mario Sabatelli; Stefano Lancellotti; Emiliana Meleo; Raimondo De Cristofaro; Filippo Crea
Journal:  ESC Heart Fail       Date:  2019-06-11

Review 7.  Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.

Authors:  Matthias Boentert
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-27       Impact factor: 5.081

8.  Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives.

Authors:  Matthias Boentert
Journal:  Nat Sci Sleep       Date:  2019-08-09

9.  Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.

Authors:  Erik Schönfelder; Alma Osmanovic; Lars Hendrik Müschen; Susanne Petri; Olivia Schreiber-Katz
Journal:  Orphanet J Rare Dis       Date:  2020-06-12       Impact factor: 4.123

10.  Amyotrophic lateral sclerosis alters the metabolic aging profile in patient derived fibroblasts.

Authors:  Margarita Gerou; Benjamin Hall; Ryan Woof; Jessica Allsop; Stephen J Kolb; Kathrin Meyer; Pamela J Shaw; Scott P Allen
Journal:  Neurobiol Aging       Date:  2021-04-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.